Sign in
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Journal article   Open access   Peer reviewed

A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity

Sven J van der Lee, Olivia J Conway, Iris Jansen, Minerva M Carrasquillo, Luca Kleineidam, Erik van den Akker, Isabel Hernández, Kristel R van Eijk, Najada Stringa, Jason A Chen, …
Acta neuropathologica, Vol.138(2), pp.237-250
08/01/2019
DOI: 10.1007/s00401-019-02026-8
PMCID: PMC6660501
PMID: 31131421
url
https://doi.org/10.1007/s00401-019-02026-8View
Published (Version of record) Open Access

Abstract

Mutation Neuroimaging Alleles Alzheimer Disease - genetics Amyotrophic Lateral Sclerosis - genetics Brain - immunology Brain - metabolism Brain - pathology Dementia - genetics Frontotemporal Dementia - genetics Genetic Predisposition to Disease Genome-Wide Association Study Humans Lewy Body Disease - genetics Longevity - genetics Microglia - metabolism Multiple Sclerosis - genetics Parkinson Disease - genetics Phospholipase C gamma - genetics Risk

Details

Logo image